MoneyWorks4Me

Everest Organics - Quaterly Results

11 Feb 2025 Evaluate
The sales is pegged at Rs. 420.51 millions for the December 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 525.07 millions during the year-ago period.Net Profit witnessed a 6611.76% growth almost the double from Rs. 0.17 millions to Rs. 11.41  millions  of same quarter last year.OP of the company witnessed a marginal growth to 40.23 millions from 29.29 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 420.51 525.07 -19.91 1185.44 1446.25 -18.03 1972.41 1830.48 7.75
Other Income 0.05 1.30 -96.15 4.71 5.89 -20.03 8.86 69.44 -87.24
PBIDT 40.23 29.29 37.35 42.57 86.15 -50.59 118.72 78.73 50.79
Interest 14.04 14.47 -2.97 40.43 42.24 -4.29 54.66 33.10 65.14
PBDT 26.19 14.82 76.72 2.14 43.91 -95.13 64.06 45.63 40.39
Depreciation 14.68 13.30 10.38 44.04 39.44 11.66 57.95 44.74 29.53
PBT 11.51 1.52 657.24 -41.90 4.47 -1037.36 6.11 0.89 586.52
TAX 0.10 1.35 -92.59 0.18 3.67 -95.10 4.71 2.72 73.16
Deferred Tax 0.10 1.15 -91.30 0.18 2.97 -93.94 3.71 2.57 44.36
PAT 11.41 0.17 6611.76 -42.08 0.80 -5360.00 1.40 -1.83 -176.50
Equity 80.00 80.00 0.00 80.00 80.00 0.00 80.00 80.00 0.00
PBIDTM(%) 9.57 5.58 71.50 3.59 5.96 -39.71 6.02 4.30 39.94
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..